Posts in tag

PBAC


Endometriosis, OCP drug listings recommended to increase access and multiple treatment options for women The PBAC has recommended unrestricted benefit listings of drospirenone with ethinylestradiol (Yaz and Yasmin) oral contraceptive …

Chronic pain patients who are struggling to cover the costs of medicinal cannabis treatments are being urged to talk to their pharmacists  Legislation requiring medications to be approved by the …

PBAC recommends PBS listing of drug to treat endometriosis pain, noting need for new treatments for the condition The PBAC has recommended PBS listing of Ryeqo for treatment of moderate …

Outgoing MSAC chair, Professor Robyn Ward, will take on the leadership of the PBAC this May  Professor Ward, the executive dean of the Faculty of Medicine and Health at the …

Government extends Safety Net early supply rule for 60-day scripts to reduce medicines wastage  Changes to the Pharmaceutical Benefits Scheme (PBS) Safety Net early supply rule come into effect today …

Eli Lilly’s Mounjaro would need “substantial price reduction”, says PBAC Mounjaro, the type-2 diabetes medication that the New York Times recently predicted “’could overshadow Ozempic” has been refused funding via …

Community pharmacists are being urged to “keep the pressure on the government” to limit the adverse impacts of 60-day dispensing  Government officials need to restart negotiations with community pharmacy leaders …

Trust between the government and community pharmacy is broken, Professor Trent Twomey, Pharmacy Guild of Australia national president believes  Labor’s decision to push ahead with its plans for 60-day dispensing …

The controversial decision to restrict prescribing fluticasone propionate for young children has been reversed in a move welcomed by the Guild But families and pharmacists have been left without clear …

Increasing dispensing limits from 30 to 60 days’ supply of medication through the Pharmaceutical Benefits Scheme (PBS) is back on the agenda  Ahead of the federal Budget in May, Mark …

PBAC gives OK to imports of drought-stricken Ozempic and Trulicity but won’t allow supplier to charge higher price  Emergency imported supplies of overseas supplies of shortage-plagued Ozempic (semaglutide) and Trulicity …

Decrease in esomeprazole and increase in pantoprazole scripts likely due to restriction changes, says PBAC, though full picture obscured by lack of OTC and private data Restriction changes established in …